Copertina

Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Peng Xu, Raymond S. M. Wong, Xiaoyu Yan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pharmacokinetic and pharmacodynamic modelling of continuous erythropoiesis receptor activator in children: A comprehensive analysis and real‐world data validation
di: Samer Mouksassi, et al.
Pubblicazione: (2025)

Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction
di: David F. Colón, et al.
Pubblicazione: (2024)

Population pharmacokinetics of long‐term hydroxychloroquine therapy in patients with rheumatic diseases
di: Chunlan Yang, et al.
Pubblicazione: (2024)

TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate
di: Michelle Y. Meng, et al.
Pubblicazione: (2024)

Vestibular modulation by stimulant derivatives in a pentameric ligand‐gated ion channel
di: Emelia Karlsson, et al.
Pubblicazione: (2025)

Setting of initiation and factors associated with antidepressant use on entry to long‐term care facilities
di: Georgina A. Hughes, et al.
Pubblicazione: (2025)

Pathway‐level mutational signatures predict breast cancer outcomes and reveal therapeutic targets
di: Máté Posta, et al.
Pubblicazione: (2025)

Hair analysis of formoterol as a novel tool to assess long‐term inhalation medication adherence: Data from the TRICOLON trial
di: Liz J. A. Cuperus, et al.
Pubblicazione: (2026)

Validity of the Medication Safety Self‐Assessment for Long‐Term Care tool in Australian long‐term care: a RAND appropriateness method study
di: Ramesh Sharma Poudel, et al.
Pubblicazione: (2025)

Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response
di: Magnus Ingelman‐Sundberg, et al.
Pubblicazione: (2024)

TREM2 activation suppresses central sensitisation by promoting autophagy in a chronic migraine model with recurrent nitroglycerin stimulation in mice
di: Suifa Hu, et al.
Pubblicazione: (2026)

How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
di: Ralf Weiskirchen, et al.
Pubblicazione: (2025)

Development of a long‐acting relaxin for the treatment of pulmonary hypertension
di: John Diener, et al.
Pubblicazione: (2026)

A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
di: Dongdong Zhang, et al.
Pubblicazione: (2025)

Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1‐mediated autophagy
di: Yan Zou, et al.
Pubblicazione: (2025)

Medication adherence—Everybody's problem but nobody's responsibility?
di: Amy Hai Yan Chan, et al.
Pubblicazione: (2024)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
di: H. Ongun Onaran, et al.
Pubblicazione: (2024)

Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent
di: Bing Shang, et al.
Pubblicazione: (2024)

Enzyme‐responsive 612‐AYR nanoparticles for targeted inhibition of B4GALT3‐mediated ITGB1 glycosylation in hepatocellular carcinoma
di: Xiaohui Yu, et al.
Pubblicazione: (2026)

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses
di: De‐Kui Qiu, et al.
Pubblicazione: (2026)

Genetic polymorphisms influencing antihypertensive drug responses
di: Jana El Cheikh, et al.
Pubblicazione: (2024)

Correction to “Genetic polymorphisms influencing antihypertensive drug responses”
Pubblicazione: (2025)

Network medicine and systems pharmacology approaches to predicting adverse drug effects
di: Alessio Funari, et al.
Pubblicazione: (2024)

Kynurenic acid as a promising therapeutic agent in renal fibrosis: dual modulation of fibrosis and immune crosstalk
di: Sona Sykorova, et al.
Pubblicazione: (2026)

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
di: Qingxiang Lin, et al.
Pubblicazione: (2024)

Nervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts
di: Chenxu Li, et al.
Pubblicazione: (2025)

Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs
di: Éva Bertalan, et al.
Pubblicazione: (2024)

Characterisation of neurogenic lipolytic responses in white adipose tissue ex vivo
di: Kayleigh E. Goddard, et al.
Pubblicazione: (2025)

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases
di: Bruno Poirier, et al.
Pubblicazione: (2024)

Baclofen modulates the immune response after spinal cord injury with locomotor benefits
di: Nídia de Sousa, et al.
Pubblicazione: (2025)

The metalloproteinase ADAM17 promotes acute lung inflammatory responses during pancreatitis
di: Shermin Chan, et al.
Pubblicazione: (2026)

Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges
di: Jia‐Peng Li, et al.
Pubblicazione: (2024)

Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis
di: Danli Cao, et al.
Pubblicazione: (2025)

Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer
di: Rui Wang, et al.
Pubblicazione: (2025)

Insulin‐degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver
di: Marine Andres, et al.
Pubblicazione: (2024)

Hydroxymethylglutaryl‐CoA reductase activity is essential for mitochondrial β‐oxidation of fatty acids to prevent lethal accumulation of long‐chain acylcarnitines in the mouse liver
di: Edgars Liepinsh, et al.
Pubblicazione: (2024)

Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase‐targeted protein degrader BGB‐16673
di: Yue Wu, et al.
Pubblicazione: (2024)

Piezo1‐mediated regulation of smooth muscle cell volume in response to enhanced extracellular matrix rigidity
di: Robert T. Johnson, et al.
Pubblicazione: (2024)

AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin
di: Yi‐Ting Huang, et al.
Pubblicazione: (2024)

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss
di: Anna Pisani, et al.
Pubblicazione: (2024)